Novo Nordisk is positioning the company’s type 2 diabetes treatment Ozempic (semaglutide) as an anti-obesity treatment, as data published in the New England Journal of Medicine shows the once-weekly dose of the glucagon-like peptide-1 analog significantly reduced weight in patients over the course of 68 weeks.

Older adults who cut back on the amount of vegetable protein in their diets may be more likely to experience age-related health problems than their peers who increase the amount of plant protein they eat, a Spanish study suggests.

A research review evaluates how well various measures work to reduce consumption of sugary sodas and other sweetened drinks.

The Food and Drug Administration is giving restaurants and other food purveyors an additional year to comply with new rules that require calorie counts on menus, a response to concerns […]